由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Immigration版 - EB1b求评估
相关主题
我这种情况能试pp吗审稿机会 (Pharmaceutical Sciences)
求评估EB1B和策略EB1A eval-insufficient citations to 1st author paper
弱case EB1B求评估也来问问审稿的问题
Update: I 140 approved after RFEEB1A 可以吗?
review Chinese manuscripts攒人品-要review的模板
EB1A律师求推荐Can I count this as one review (I cannot type Chinese in this computer, sorry)
这种杂志的Editorial Board Member有用吗?EB1A求评估
review opportunity_4. 药物治疗学Phd学生是否接受杂志Editorial Board的邀请
相关话题的讨论汇总
话题: chinese话题: english话题: paper话题: author话题: manuscript
进入Immigration版参与讨论
1 (共1页)
j******9
发帖数: 128
1
Ph.D. from China
Majority:pharmacology
The first author English paper 3(IF:2-5)
The first author Chinese paper:4
The first author conference abstract or post:2(English),2(Chinese)
Book chapter:2
The second author Chinese paper:5
Citation: English paper(25), Chinese paper(70)
Review:20(English manuscript(IF:0.6-3.6):16, Chinese manuscript:4)
Editorial Board: 2 new journals
Reference letter:1(Japan),1(English journal editor),1(Harvard),1(Yale), 1(
Canada),1(Korean),3(USA).
Thanks
d***y
发帖数: 8107
2
gogogo
r******8
发帖数: 204
3
估计要等等。中文引用要是打算用的话还得都翻译过来。
j******9
发帖数: 128
4
........
H*0
发帖数: 1961
5
Good enough!

【在 j******9 的大作中提到】
: Ph.D. from China
: Majority:pharmacology
: The first author English paper 3(IF:2-5)
: The first author Chinese paper:4
: The first author conference abstract or post:2(English),2(Chinese)
: Book chapter:2
: The second author Chinese paper:5
: Citation: English paper(25), Chinese paper(70)
: Review:20(English manuscript(IF:0.6-3.6):16, Chinese manuscript:4)
: Editorial Board: 2 new journals

s*****h
发帖数: 564
6
good engough
1 (共1页)
进入Immigration版参与讨论
相关主题
Phd学生是否接受杂志Editorial Board的邀请review Chinese manuscripts
有什么办法证明杂志credits a small, elite group of refereesEB1A律师求推荐
Question这种杂志的Editorial Board Member有用吗?
请大家帮我看看这么和秘书催审稿行么?review opportunity_4. 药物治疗学
我这种情况能试pp吗审稿机会 (Pharmaceutical Sciences)
求评估EB1B和策略EB1A eval-insufficient citations to 1st author paper
弱case EB1B求评估也来问问审稿的问题
Update: I 140 approved after RFEEB1A 可以吗?
相关话题的讨论汇总
话题: chinese话题: english话题: paper话题: author话题: manuscript